Powered by: Motilal Oswal
2026-07-28 03:29:08 pm | Source: Bajaj Broking
High Conviction MTF Pick :- Sun Pharmaceutical Industries 28th July 2026 by Bajaj Broking
High Conviction MTF Pick :- Sun Pharmaceutical Industries 28th July 2026 by Bajaj Broking

Sun Pharmaceutical Industries Ltd

Buying Range: 1950 - 1980 Target: 2180 Return Opportunity: 11%

Technical Outlook

The stock has generated a breakout above the last 21 months consolidation range of 1960 - 1583 signaling strength and offers fresh entry opportunity .

The base of the entire consolidation is placed at the 12 months EMA highlighting positive bias . The current month low of 1860 will act as immediate support for the stock in the medium term .

Sun Pharma has exhibited strong relative strength on the monthly chart by retracing its 16- month decline (Rs1,960 –Rs1,583 ) in just five months . Such a faster retracement signifies robust demand and a decisive shift in momentum . Further, the stock has broken out above a major consolidation range, indicating a structural trend reversal and the formation of a higher base . This price behaviour points towards a continuation of the primary uptrend and underscores the stock's long - term bullish structure .

The stock is maintaining a strong uptrend with a series of higher highs and higher lows on the monthly chart . Having entered uncharted territory, it is well placed to extend its up move towards 2180 , the 161.8% external retracement of the 1960 –1583 decline, over the coming quarters .

The monthly 14 periods RSI is in up trend, it has recently generated a buy signal moving above its nine periods average thus supports the positive bias in the stock

 

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here